International Clinical Trial: A single-arm, open-label phase II clinical study to evaluate the efficacy and safety of low-dose radiotherapy (LDRT) combined with chemioimmunotherapy (toripalimab combined with paclitaxel and cisplatin) in patients with recurrent or advanced esophageal squamous cell carcinoma

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125208) titled 'A single-arm, open-label phase II clinical study to evaluate the efficacy and safety of low-dose radiotherapy (LDRT) combined with chemioimmunotherapy (toripalimab combined with paclitaxel and cisplatin) in patients with recurrent or advanced esophageal squamous cell carcinoma' on May 22.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Hospital of Jiaxing

Condition: Recurrent or advanced esophageal squamous cell carcinoma

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-05-25

Target Sample Size: Test group:40;

Countries of Recruitment: Ch...